New Ultrasensitive Blood Test Detects Advanced Tau Pathology in Alzheimer’s Disease
“I think scalability is the next step,” said Nicholas Ashton, PhD, senior director of Banner’s Fluid Biomarker Program at Banner Sun Health Research Institute in Sun City, Arizona, describing a … Read More